PLPL (Plandai Biotechnology) Stock Based Compensation: $0.00 Mil (TTM As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Plandai Biotechnology Stock Based Compensation?

Plandai Biotechnology PLPL -90.00% Stock Based Compensation is $0.00 Mil as of Jun. 2023.

Plandai Biotechnology's Stock Based Compensation for the six months ended in Jun. 2023 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Plandai Biotechnology Stock Based Compensation Related Terms

Plandai Biotechnology Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Plandai Biotechnology's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plandai Biotechnology Stock Based Compensation Chart

Plandai Biotechnology Annual Data
Trend Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.86 5.61 0.00 0.00 0.00

Plandai Biotechnology Semi-Annual Data
Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 5.61 0.00 0.00 0.00

Plandai Biotechnology Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

What does a Stock Based Compensation of $0.00 Mil mean?
Plandai Biotechnology (PLPL) has a Stock Based Compensation of $0.00 Mil as of Jun. 2023. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Plandai Biotechnology and its competitors.
Is Plandai Biotechnology's Stock Based Compensation too high?
Plandai Biotechnology's current Stock Based Compensation is $0.00 Mil.
How does Plandai Biotechnology's Stock Based Compensation compare to CRGH and TCRI?
Plandai Biotechnology's Stock Based Compensation of $0.00 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Business Services company?
A good Stock Based Compensation depends on the Business Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Plandai Biotechnology and its competitors. Plandai Biotechnology's current Stock Based Compensation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plandai Biotechnology stock overvalued right now?
Plandai Biotechnology (PLPL) has a current Stock Based Compensation of $0.00 Mil. The current Stock Based Compensation is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Plandai Biotechnology (PLPL), the current Stock Based Compensation is $0.00 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Plandai Biotechnology Business Description

Address Xinyi Road, Sector 5, No. 7, 57th Floor - 1, Xinyi District, Taipei, TWN, 330
Plandai Biotechnology Inc is engaged in catering and catering management operations in Taiwan.